UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

           September 14, 2007           
(Date of earliest event reported)

LABORATORY CORPORATION OF
AMERICA HOLDINGS

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 7.01. Regulation FD Disclosure

On September 14, 2007, Laboratory Corporation of America^® Holdings (LabCorp^®) (NYSE: LH), announced that David P. King, Chief Executive Officer and Bradford T. Smith, Executive Vice President, Corporate Affairs, are scheduled to speak at the Bank of America 2007 Investment Conference in San Francisco, CA. LabCorp’s presentation is planned for Tuesday, September 18, 2007 at 9:00 a.m. (Pacific Time).

Exhibits

99.1 Press Release dated September 14, 2007

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Laboratory Corporation of America Holdings (Registrant)
Date: September 14, 2007	By:	/s/Bradford T. Smith
		Bradford T. Smith, Executive Vice President and Secretary